Table 3.
Demographics and clinic characteristics of patients.
| Patient | With IAH group (mean ± SD)(median (min–max)) | Without IAH group(mean ± SD)(median (min–max)) | P-value |
| Age (month) | 58.47 ± 53.148 (3–156) | 52.75 ± 42.942 (2–132) | 0.984 |
| Body weight (kg) | 13.7 ± 7.514.5 (3.7–25) | 12.9 ± 8.113.5 (3.5–24) | 0.599 |
| PIM II | 63.2 ± 13.568 (36–80) | 63.8 ± 21.264 (28–98) | 0.984 |
| PRISM III | 27. 8 ± 6.128 (17–39) | 25.1 ± 8.324 (12–39) | 0.281 |
| PELOD | 29.6 ± 10.332 (10–44) | 23.2 ± 10.820 (12–44) | 0.086 |
| BUN (mg/dL) | 29.4 ± 28.824 (0.53–119) | 17.3 ± 13.912 (3–53) | 0.175 |
| Creatine (mg/dL) | 1 ± 0.570.87 (0.4–2.6) | 0.8 ± 0.750.51 (0.15–2.7) | 0.072 |
| Urine output (mL/kg/h) | 5 ± 10.41.4 (5–42) | 3.2 ± 2.13 (1–10) | 0.140 |
| Capillary refilling time (s) | 3.8 ± 1.14 (2–6) | 2.5 ± 0.72 (2–4) | 0.003 |
| MAP-mean (mmHg) | 64.8 ± 16.260 (41.2–94.5) | 75.4 ± 15.972.3 (56.7–110.7) | 0.072 |
| APP-mean (mmHg) | 52.9 ± 16.546.7 (26.2–81) | 66.9 ± 16.563.5 (47.5–104.2) | 0.014 |
| Lactate-mean (mmol/L) | 7.5 ± 7.45.1 (1.7–31) | 2.7 ± 1.32.1 (1.2–5.6) | 0.007 |
| mesenteric-rSO2-mean (%) | 44.9 ± 11.844 (26.5–70.5) | 57.9 ± 8.856.2 (45.7–73.5) | 0.002 |
| renal-rSO2-mean (%)IAP (mmHg)ScvO2 (%)VISEF (%)Hb (g/dL) | 50.6 ± 1251.2 (25.7–67)11.8 ± 1.511.2 (10–15)59.6 ± 11.262 (38–76)40.4 ± 25.942 (0–83)51.4 ± 11.449 (30–72)9.2 ± 1.98.3 (7–13) | 64.2 ± 9.764.7 (44.5–80.7)8.2 ± 1.28.8 (6.5–9.7)71.1 ± 12.272 (45–90)15.8 ± 24.30 (0–57)61.8 ± 10.865 (37–75)10.3 ± 1.610.5 (7–13) | 0.004<0.0010.0240.0240.0120.093 |